Based on downstream analysis, 5 hub genes, including CDK1, CDC20, CCNB1, CENPF, and MAD2L1, that could play a critical role in the early diagnosis, tumour stage, and poor outcomes of HBV-HCC were identified. This evidence concerns the gene MAD2L1 and neoplasm.